As AI gets more curious, security gaps widen. Explore the risks of prompt exfiltration and autonomous model behavior.

Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its ...

Recursion Pharmaceuticals (RXRX) saw its shares surge in the last session with trading volume being higher than average. The ...

Detailed price information for Tyler Technologies (TYL-N) from The Globe and Mail including charting and trades.